Table 2.
Category / Subcategory | Definition | Illustration |
---|---|---|
1. Adverse effects of drug therapy | Adverse clinical effects of drug therapy, including adverse drug reactions and drug contraindications | Hyperkalemia on ACE inhibitors |
| ||
2. Non-adherence to therapeutic and monitoring plan | Improper use of medications, including non-adherence, improper dose and dosing frequency (e.g., with risk of overdose), and problems with followup monitoring. Often discussed as a safety issue | |
Cognitive capacity | Patient confusion about proper use or monitoring of medications | Cognitive impairment |
Access to care and environmental constraints | Environmental and systems factors impacting proper use or monitoring of medications | Lack of health insurance impacting ability to pay for medications |
Patient understanding * | Challenges to communication between patient and their physician or the health system | Poor health systems literacy impacting patient ability to obtain follow-up care |
Transitions of care * | Challenges to physician-physician communication as patient is transferred from one clinician or care setting to another | Discharge from inpatient to outpatient care with fear that patient will not receive follow-up labs after being started on ACE inhibitor |
Cross-cutting and non-specific barriers | Reason involving more than one of the above sub-categories, or sufficiently general to prevent classification into a specific sub-category | Cognitive impairment in absence of caregiver to assist with medication administration |
| ||
3. Patient preferences | Patient reluctance to take medications due to preferences, health beliefs, and goals of care. | |
Patient preferences and beliefs | Same as general category definition | Patient refusal to add more medications to current regimen |
Patient understanding * | As above (see “non-adherence to therapeutic and monitoring plan” category) | Language barriers that impede clinician attempts to understand and overcome patient reluctance to use medications |
Cross-cutting and non-specific barriers | Reason involving more than one of the above sub-categories, or sufficiently general to prevent classification into a specific sub-category | Non-English-speaking patients with non-scientific approach to medicine |
| ||
4. Co-management and transitions of care | Patient receiving care from more than one physician or health system | |
Co-management in ongoing care | Delegation of responsibility in ongoing care of a patient, or other failure to coordinate ongoing care. | Primary care physician defers responsibility for heart failure care to patient’s cardiologist |
Transitions of care * | As above (see “non-adherence to therapeutic and monitoring plan” category) | As above |
Cross-cutting or non-specific barriers | Reason involving more than one of the above sub-categories, or sufficiently general to prevent classification into a specific sub-category | Receiving physician not understanding reasons why patient is not on a recommended drug |
| ||
5. Prioritization and patient benefit | Prioritization among competing demands for time, and perceived benefit of the guideline-recommended intervention | |
Prioritization and time limitations | No long term reason not to prescribe, but cannot practically address recommended medications until other issues have stabilized | Acute medical or psychiatric illness |
Limited or uncertain benefit | Uncertainty that patient will derive net benefit from drug | Patient with limited life expectancy; patient with borderline or changing ejection fraction |
These sub-categories are shared between 2 categories.